Amy Simon
Chief Tech/Sci/R&D Officer at BEAM THERAPEUTICS INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Amy Simon is Chief Medical Officer for Beam Therapeutics, Inc. In the past Dr. Simon held the position of Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. Dr. Simon received an undergraduate degree from Harvard University and a doctorate from Tufts University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0.09% | 02/04/2024 | 70,060 ( 0.09% ) | 2 M $ | 31/03/2024 |
Amy Simon active positions
Companies | Position | Start |
---|---|---|
BEAM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 15/03/2021 |
Former positions of Amy Simon
Companies | Position | End |
---|---|---|
Tufts University | Corporate Officer/Principal | - |
Graduate School of Biomedical Sciences | Corporate Officer/Principal | - |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Amy Simon
Harvard University | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
BEAM THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Graduate School of Biomedical Sciences |
- Stock Market
- Insiders
- Amy Simon